It is challenging to find anyone who has not had their life impacted by cancer, a debilitating illness, or a degenerative condition. These diseases affect not only the patient’s life, but those of their families and their surrounding community. The advancement of medicine is changing this trajectory, and that advancement will go right through Phoenix.Continue reading
Category Archives: AZBio News
University of North Dakota Centers for Family Medicine Pursuing Research Study on Blood-based Colorectal Cancer Screening
Phoenix, Arizona, June 1, 2021 – The University of North Dakota (UND) Center for Family Medicine (CFM) in Bismarck is partnering with Beacon Biomedical Inc. to study a new blood-based colorectal cancer (CRC) screening test, called BeScreened-CRC, for North Dakota patients.Continue reading
ASU’s new Health Futures Center provides fresh intersections with Mayo Clinic to transform health care
State-of-the-art facility designed to support medical research, learning and entrepreneurshipContinue reading
C-Path Virtual Workshop to Feature Latest Advances in Clinical Trials for T1D
More than 300 Attendees and 20 Speakers Are Expected to Participate in the International Workshop,
June 15-16Continue reading
Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform
Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform
Accelerates Caris’ rapid growth as the market leader reshaping precision oncology through basic science research and the application of artificial intelligence to one of the largest clinico-genomic databases
Capital raise represents one of the largest private financings in precision medicine supported by a diverse, high-quality syndicate of leading investorsContinue reading
Castle Biosciences Supports the American Skin Association with Research Grant
The ASA Castle Biosciences Research Grant Melanoma was awarded to Joel Sunshine, M.D., Ph.D., Johns Hopkins School of Medicine
Rays of Hope Conference Brings Brain Injury Survivors Together
Rays of Hope provides an annual opportunity for survivors, their families, and caregivers to share experiences on their respective roads to recovery. This emotional connection often leads to greater insights about the invisible disability known as brain injury.Continue reading
CSL Behring Announces Closing of Global Commercialization and License Agreement with uniQure for etranacogene dezaparvovec
• Etranacogene dezaparvovec (AMT-061) is an investigational gene therapy that may potentially provide people with hemophilia B with years of functional levels of Factor IX, a blood-clotting protein that prevents excessive bleeding.
• uniQure will complete the Phase 3 HOPE-B trial and scale up manufacture for initial commercial supply under an agreed plan with CSL Behring.
TGen-led study of more than 70,000 individuals links dementia to smoking and cardiovascular disease
Significantly, women impaired more by smoking; men impaired more by cardiovascular disease
PHOENIX, Ariz. — May 13, 2021 — In the largest study of the associations between smoking and cardiovascular disease on cognitive function, researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, found both impair the ability to learn and memorize; and that the effects of smoking are more pronounced among females, while males are more impaired by cardiovascular disease.